MedPath

Cellincells

🇰🇷South Korea
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

Long-Term Follow-up of Adult With Atorpphic Scars Treated With TRTP-101

Recruiting
Conditions
Atrophic Scar
First Posted Date
2024-05-30
Last Posted Date
2024-10-08
Lead Sponsor
CellinCells
Target Recruit Count
6
Registration Number
NCT06435884
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

Safety and Tolerability of Autologous Adipose-derived Mesenchymal Stem Cells Therapy in Adults With Atrophic Scars

Phase 1
Completed
Conditions
Atrophic Scar
Interventions
First Posted Date
2024-01-18
Last Posted Date
2025-08-12
Lead Sponsor
CellinCells
Target Recruit Count
3
Registration Number
NCT06210919
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.